Literature DB >> 14592978

C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.

Estelle Duprez1, Katharina Wagner, Heike Koch, Daniel G Tenen.   

Abstract

In acute promyelocytic leukemia (APL), the translocation t(15;17) induces a block at the promyelocytic stage of differentiation in an all-trans-retinoic acid (ATRA)-responsive manner. Here we report that upon treatment with ATRA, t(15;17) cells (NB4) reveal a very rapid increase in protein level and binding activity of C/EBPbeta, a C/EBP family member, which was not observed in an ATRA-resistant NB4 cell line. We further provide evidence that ATRA mediates a direct increase of C/EBPbeta, only in PML-RARA (promyelocytic leukemia-retinoic acid receptor alpha)-expressing cells. In addition, transactivation experiments indicate that the PML-RARA fusion protein, but not PML-RARA mutants defective in transactivation, strongly transactivates the C/EBPbeta promoter. These results suggest that PML-RARA mediates ATRA-induced C/EBPbeta expression. Finally, we demonstrate the importance of C/EBPbeta in granulocytic differentiation. We show that not only does C/EBPbeta induce granulocytic differentiation of non-APL myeloid cell lines independent of addition of ATRA or other cytokines, but also that C/EBPbeta induction is required during ATRA-induced differentiation of APL cells. Taken together, C/EBPbeta is an ATRA-dependent PML-RARA target gene involved in ATRA-induced differentiation of APL cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592978      PMCID: PMC275413          DOI: 10.1093/emboj/cdg556

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells.

Authors:  L T Smith; S Hohaus; D A Gonzalez; S E Dziennis; D G Tenen
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

2.  The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors.

Authors:  A M Näär; J M Boutin; S M Lipkin; V C Yu; J M Holloway; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

3.  Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages.

Authors:  T Tanaka; S Akira; K Yoshida; M Umemoto; Y Yoneda; N Shirafuji; H Fujiwara; S Suematsu; N Yoshida; T Kishimoto
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

4.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

Authors:  D E Zhang; P Zhang; N D Wang; C J Hetherington; G J Darlington; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.

Authors:  J L Grisolano; R L Wesselschmidt; P G Pelicci; T J Ley
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

6.  Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.

Authors:  E Duprez; J R Lillehaug; M P Gaub; M Lanotte
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

7.  Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.

Authors:  A Kakizuka; W H Miller; K Umesono; R P Warrell; S R Frankel; V V Murty; E Dmitrovsky; R M Evans
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

8.  Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties.

Authors:  M Olive; S C Williams; C Dezan; P F Johnson; C Vinson
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

9.  Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice.

Authors:  I Screpanti; L Romani; P Musiani; A Modesti; E Fattori; D Lazzaro; C Sellitto; S Scarpa; D Bellavia; G Lattanzio
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

10.  PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.

Authors:  A Perez; P Kastner; S Sethi; Y Lutz; C Reibel; P Chambon
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  58 in total

1.  C/EBPβ and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro.

Authors:  Kaiji Zhang; Jian Li; Wentong Meng; Hongyun Xing; Yiming Yang
Journal:  Int J Hematol       Date:  2010-10-28       Impact factor: 2.490

2.  Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.

Authors:  Karen Keeshan; Pauline Vieugué; Shahzya Chaudhury; Loveena Rishi; Coline Gaillard; Lu Liang; Elaine Garcia; Takuro Nakamura; Nader Omidvar; Scott C Kogan
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

3.  MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.

Authors:  Li Yin; Zekui Wu; David Avigan; Jacalyn Rosenblatt; Richard Stone; Surender Kharbanda; Donald Kufe
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

4.  Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.

Authors:  Jun Zhou; Laurent Pérès; Nicole Honoré; Rihab Nasr; Jun Zhu; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

5.  Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells.

Authors:  Tadayuki Akagi; Takayuki Saitoh; James O'Kelly; Shizuo Akira; Adrian F Gombart; H Phillip Koeffler
Journal:  Blood       Date:  2007-12-04       Impact factor: 22.113

6.  PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.

Authors:  Hitoshi Yoshida; Hitoshi Ichikawa; Yusuke Tagata; Takuo Katsumoto; Kazunori Ohnishi; Yukihiro Akao; Tomoki Naoe; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

7.  Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation.

Authors:  Brenda J Chyla; Isabel Moreno-Miralles; Melissa A Steapleton; Mary Ann Thompson; Srividya Bhaskara; Michael Engel; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 8.  Targeting of leukemia-initiating cells in acute promyelocytic leukemia.

Authors:  Ugo Testa; Francesco Lo-Coco
Journal:  Stem Cell Investig       Date:  2015-04-29

9.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 10.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.